Removal of the N-terminal hexapeptide from human β2-microglobulin facilities protein aggregation and fibril formation

Protein Science

Volumn 9, Issue 5, 2000, Pages 831-845

  Esposito, G ^a   Michelutti, R ^a   Verdone, G ^a   Viglino, P ^a   Hernandez H ^b   Robinson, C V ^b   Amoresano, A ^c   Dal Piaz, F ^c   Monti, M ^c   Pucci, P ^c   Mangione, P ^d,e   Stoppini, M ^d   Merlini, G ^d,e   Ferri, G ^d   Bellotti, Vittorio ^d,e  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Amyloidosis; Hydrogen exchange mass spectrometry; Limited proteolysis; NMR; Protein folding; 2 microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN; HEXAPEPTIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; DISULFIDE BOND; FIBER; GEL FILTRATION; HUMAN; MASS SPECTROMETRY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE;

EID: 18244412979     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.9.5.831     Document Type: Article

References (47)

1. Bax A, Davis DG. 1985. MLEV-17 based two dimensional homonuclear magnetization transfer spectroscopy. J Mag Reson 65:355-360.
2. Bellotti V, Stoppini M, Mangione P, Sunde M, Robinson CV, Asti L, Brancaccio D, Ferri G. 1998. β2-microglobulin can be refolded into a native state from ex vivo amyloid fibrils. Eur J Biochem 258:61-67.
3. Bjorkman PJ, Saper MA, Samaroui B, Bennet WS, Strominger JL, Wiley DC. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506-512.
4. Booth D, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, Fraser P, Hawkins PN, Dobson CM, Radford SE, Blake CCF, Pepys M. 1997. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385:787-793.
5. Botto M, Hawkins PN, Bickerstaff MC, Herbert J, Bygrave AE, McBride A, Hutchinson WL, Tennent GA, Walport MJ, Pepys MB. 1997. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nat Med 8:855-859.
6. Braunschweiler L, Ernst RR. 1983. Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy. J Magn Reson 53:521-528.
7. Canet D, Sunde M, Last AM, Miranker A, Spencer A, Robinson C, Dobson CM. 1999. Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease related variants. Biochemistry 38:6419-6427.
8. Capeiller-Blandin C, Delaveau T, Descamps-Latscha B. 1991. Structural modifications of human β2-microglobulin treated with oxygen-derived radicals. Biochem J 277:175-182.
9. Connors LH, Shirahama T, Skinner M, Fenves A, Cohen AS. 1985. In vitro formation of amyloid fibrils from intact beta2-microglobulin. Biochem Biophys Res Commun 131:1063-1068.
10. Finn BE, Chen X, Jennings PA, Saalau-Bethell SM. 1992. Principles of protein stability. Part 1: Reversible unfolding of protein: Kinetic and thermodynamic analysis. In: Rees AR, Stenderberg MJE, Wetzel R, eds. Protein engineering. Oxford: IRL Oxford University Press. pp 167-189.
11. Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, et al. 1985. A new form of amyloid protein associated with hemodialysis was identified as β2-microglobulin. Biochem Biophys Res Commun 129:701-706.
12. Güntert P, Mumenthaler C, Wüthrich K. 1997. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J Mol Biol 273:283-298.
13. Hooke SD, Eyles SJ, Miranker A, Radford SE, Robinson CV, Dobson CM. 1995. Co-operative elements in protein folding monitored by electrospray ionization mass spectrometry. J Am Chem Soc 117:7548-7549.
14. Isenman DE, Painter RH, Dorrington KJ. 1975. The structure and function of immunoglobulin domains: Studies with β2-microglobulin on the role of the intrachain disulfide bond. Proc Natl Acad Sci USA 72:548-552.
15. Jeener J, Meier BH, Bachmann P, Ernst RR. 1979. Investigation of exchange processes by two-dimensional NMR spectroscopy. J Chem Phys 71:286-292.
16. Kelly JW. 1997. Amyloid fibril formation and protein misassembly: A structural quest for insights into amyloid and prion disease. Structure 5:595-600.
17. Koradi R, Billeter M, Wüthrich K. 1996. MOLMOL, a program for display and analysis of macromolecular structure. J Mol Graphics 14:51-55.
18. LeVine H. 1993. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptide: Detection of amyloid aggregation in solution. Protein Sci 2:404-410.
19. Linke RP, Bommer J, Ritz E, Waldherr R, Eulitz M. 1986. Amyloid kidney stones of uremic patients consist of beta 2-microglobulin fragments. Biochem Biophys Res Commun 136:665-671.
20. Linke RP, Hampl H, Bartel-Schwarze S, Eulitz M. 1987. Beta 2-microglobulin, different fragments and polymers thereof in synovial amyloid in long-term hemodialysis. Biol Chem Hoppe Seyler 368:137-144.
21. Linke RP, Hampl H, Lobeck H, Ritz E, Bommer J, Waldherr R, Eulitz M. 1989. Lysine-specific cleavage of β2-microglobulin in amyloid deposits associated with haemodialysis. Kidney Int 36:675-681.
22. Marion D, Bax A. 1989. Baseline correction of 2D FT NMR spectra using a simple linear prediction extrapolation of the time-domain data. J Magn Reson 83:205-211.
23. Marion D, Ikura M, Bax A. 1989. Improved solvent suppression in one- and two-dimensional NMR spectra by convolution of time-domain data. J Magn Reson 84:425-430.
24. Marion D, Wüthrich K. 1983. Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of proton-proton spin-spin coupling constants in proteins. Biochem Biophys Res Commun 113:967-974.
25. Markley JL, Bax A, Arata Y, Hilbers CW, Kaptein R, Sykes BD, Wright PE, Wüthrich K. 1998. Recommendations for the presentation of NMR structures of proteins and nucleic acids. IUPAC-IUBMB-IUPAB Inter-Union Task Group on the standardization of data bases of protein and nucleic acid structures determined by NMR spectroscopy. J Biomol NMR 12:1-23.
26. Merlini G, Ascari E, Amboldi N, Bellotti V, Arbustini E, Perfetti V, Ferrari M, Zorzoli I, Marinone MG, Garini P, et al. 1995. Interaction of the anthracycline 4′-iodo-4′-deoxydoxorubicin with amyloid fibrils: Inhibition of amyloidogenesis. Proc Natl Acad Sci USA 92:2959-2963.
27. Miyata T, Oda O, Inagi R, Iida Y, Araki N, Yamada N, Horiuchi S, Taniguchi N, Maeda K, Kinoshita T. 1993. β2-microglobulin modified with advanced glycation end products is a major component of haemodialysis-associated amyloidosis. J Clin Invest 92:1243-1252.
28. Naiki H, Hashimoto N, Suzuki S, Kimura H, Nakakuki K, Gejyo F. 1997. Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro. Amyloid Int J Exp Clin Invest 4:223-232.
29. Nettleton EJ, Sunde M, Lai Z, Kelly JW, Dobson CM, Robinson CV. 1998. Tetramer to monomer dissociation and structural integrity of amyloidogenic transthyretins - Evidence from electrospray mass spectrometry. J Mol Biol 281:553-564.
30. Nicholls A, Sharp K, Honig B. 1991. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11:281-296.
31. Okon M, Bray P, Vucelic D. 1992. 1H NMR assignments and secondary structure of human β2-microglobulin in solution. Biochemistry 31:8906-8915.
32. Orrù S, Dal Piaz F, Casbarra A, Biasol G, De Francesco R, Steinkuhler C, Pucci P. 1999. Conformational changes in the NS3 protease from hepatitis C virus strain Bk monitored by limited proteolysis and mass spectrometry. Protein Sci 8:1445-1454.
33. Piotto M, Saudek V, Sklenar V. 1992. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J Biomol NMR 2:661-665.
34. Radford SE, Dobson CM. 1999. From computer simulations to human disease: Emerging themes in protein folding. Cell 97:291-298.
35. Scaloni A, Miraglia N, Orrù S, Amodeo P, Motta A, Marino G, Pucci P. 1998. Topology of calmodulin-melittin complex. J Mol Biol 277:945-958.
36. Scaloni A, Monti M, Acquaviva R, Tell G, Damante G, Formisano, Pucci P. 1999. Topology of the thyroid transcription factor I homeodomain-DNA complex. Biochemistry 38:64-72.
37. Stoppini M, Arcidiaco P, Mangione P, Giorgetti S, Brancaccio D, Bellotti V. 2000. Detection of fragments of β2-microglobulin in amyloid fibrils. Kidney Int 57:349-350.
38. Stoppini M, Bellotti V, Mangione P, Merlini G, Ferri G. 1997. Use of anti-beta 2 microglobulin mAb to study formation of amyloid fibrils. Eur J Biochem 249:21-26.
39. Sunde M, Blake CCF. 1998. From the globular to the fibrous state: Protein structure and structural conversion in amyloid formation. Quart Rev Biophys 31:1-39.
40. Sunde M, Serpell LC, Bartlam M, Fraser PE, Pepys MB, Blake CCF. 1997. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol 273:729-739.
41. Tennent GA, Lovat LB, Pepys MB. 1995. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci USA 92:4299-4303.
42. Tsunenaga M, Goto Y, Kawata Y, Hamaguchi K. 1987. Unfolding and refolding of a type kappa immunoglobulin light chain and its variable and constant fragments. Biochemistry 26:6044-6051.
43. 15N random coil chemical shifts of common amino acids. I. Investigations of nearest-neighbor effects. J Biomol NMR 5:67-81.
44. Wishart DS, Sykes BD. 1994. Chemical shifts as a tool for structure determination. Methods Enzymol 239:363-392.
45. Wood SJ, Wetzel R, Martin JD, Hurle MR. 1995. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide β/A4. Biochemistry 34:724-730.
46. Wüthrich K. 1986. NMR spectroscopy of protiens and nucleic acids. New York: Wiley & Sons.
47. Zappacosta F, Pessi A, Bianchi E, Ingallinella P, Scaloni A, Venturini S, Sollazzo M, Tramontano A, Marino G, Pucci P. 1996. Probing the tertiary stucture of proteins by limited proteolysis and mass spectrometry: The case of Minibody. Protein Sci 5:802-813.